Table of Contents Asia-Pacific Rotavirus Infections Drug Market Report 2017 1 Rotavirus Infections Drug Overview 1.1 Product Overview and Scope of Rotavirus Infections Drug 1.2 Classification of Rotavirus Infections Drug by Product Category 1.2.1 Asia-Pacific Rotavirus Infections Drug Market Size (Sales) Comparison by Types (2012-2022) 1.2.2 Asia-Pacific Rotavirus Infections Drug Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 RV-3BB 1.2.4 RV-625 1.2.5 UMN-2001 1.2.6 Rotavac-5C 1.2.7 Others 1.3 Asia-Pacific Rotavirus Infections Drug Market by Application/End Users 1.3.1 Asia-Pacific Rotavirus Infections Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Asia-Pacific Rotavirus Infections Drug Market by Region 1.4.1 Asia-Pacific Rotavirus Infections Drug Market Size (Value) Comparison by Region (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Japan Status and Prospect (2012-2022) 1.4.4 South Korea Status and Prospect (2012-2022) 1.4.5 Taiwan Status and Prospect (2012-2022) 1.4.6 India Status and Prospect (2012-2022) 1.4.7 Southeast Asia Status and Prospect (2012-2022) 1.4.8 Australia Status and Prospect (2012-2022) 1.5 Asia-Pacific Market Size (Value and Volume) of Rotavirus Infections Drug (2012-2022) 1.5.1 Asia-Pacific Rotavirus Infections Drug Sales and Growth Rate (2012-2022) 1.5.2 Asia-Pacific Rotavirus Infections Drug Revenue and Growth Rate (2012-2022) 2 Asia-Pacific Rotavirus Infections Drug Competition by Players/Suppliers, Region, Type and Application 2.1 Asia-Pacific Rotavirus Infections Drug Market Competition by Players/Suppliers 2.1.1 Asia-Pacific Rotavirus Infections Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Asia-Pacific Rotavirus Infections Drug Revenue and Share by Players/Suppliers (2012-2017) 2.2 Asia-Pacific Rotavirus Infections Drug (Volume and Value) by Type 2.2.1 Asia-Pacific Rotavirus Infections Drug Sales and Market Share by Type (2012-2017) 2.2.2 Asia-Pacific Rotavirus Infections Drug Revenue and Market Share by Type (2012-2017) 2.3 Asia-Pacific Rotavirus Infections Drug (Volume) by Application 2.4 Asia-Pacific Rotavirus Infections Drug (Volume and Value) by Region 2.4.1 Asia-Pacific Rotavirus Infections Drug Sales and Market Share by Region (2012-2017) 2.4.2 Asia-Pacific Rotavirus Infections Drug Revenue and Market Share by Region (2012-2017) 3 China Rotavirus Infections Drug (Volume, Value and Sales Price) 3.1 China Rotavirus Infections Drug Sales and Value (2012-2017) 3.1.1 China Rotavirus Infections Drug Sales Volume and Growth Rate (2012-2017) 3.1.2 China Rotavirus Infections Drug Revenue and Growth Rate (2012-2017) 3.1.3 China Rotavirus Infections Drug Sales Price Trend (2012-2017) 3.2 China Rotavirus Infections Drug Sales Volume and Market Share by Type 3.3 China Rotavirus Infections Drug Sales Volume and Market Share by Application 4 Japan Rotavirus Infections Drug (Volume, Value and Sales Price) 4.1 Japan Rotavirus Infections Drug Sales and Value (2012-2017) 4.1.1 Japan Rotavirus Infections Drug Sales Volume and Growth Rate (2012-2017) 4.1.2 Japan Rotavirus Infections Drug Revenue and Growth Rate (2012-2017) 4.1.3 Japan Rotavirus Infections Drug Sales Price Trend (2012-2017) 4.2 Japan Rotavirus Infections Drug Sales Volume and Market Share by Type 4.3 Japan Rotavirus Infections Drug Sales Volume and Market Share by Application 5 South Korea Rotavirus Infections Drug (Volume, Value and Sales Price) 5.1 South Korea Rotavirus Infections Drug Sales and Value (2012-2017) 5.1.1 South Korea Rotavirus Infections Drug Sales Volume and Growth Rate (2012-2017) 5.1.2 South Korea Rotavirus Infections Drug Revenue and Growth Rate (2012-2017) 5.1.3 South Korea Rotavirus Infections Drug Sales Price Trend (2012-2017) 5.2 South Korea Rotavirus Infections Drug Sales Volume and Market Share by Type 5.3 South Korea Rotavirus Infections Drug Sales Volume and Market Share by Application 6 Taiwan Rotavirus Infections Drug (Volume, Value and Sales Price) 6.1 Taiwan Rotavirus Infections Drug Sales and Value (2012-2017) 6.1.1 Taiwan Rotavirus Infections Drug Sales Volume and Growth Rate (2012-2017) 6.1.2 Taiwan Rotavirus Infections Drug Revenue and Growth Rate (2012-2017) 6.1.3 Taiwan Rotavirus Infections Drug Sales Price Trend (2012-2017) 6.2 Taiwan Rotavirus Infections Drug Sales Volume and Market Share by Type 6.3 Taiwan Rotavirus Infections Drug Sales Volume and Market Share by Application 7 India Rotavirus Infections Drug (Volume, Value and Sales Price) 7.1 India Rotavirus Infections Drug Sales and Value (2012-2017) 7.1.1 India Rotavirus Infections Drug Sales Volume and Growth Rate (2012-2017) 7.1.2 India Rotavirus Infections Drug Revenue and Growth Rate (2012-2017) 7.1.3 India Rotavirus Infections Drug Sales Price Trend (2012-2017) 7.2 India Rotavirus Infections Drug Sales Volume and Market Share by Type 7.3 India Rotavirus Infections Drug Sales Volume and Market Share by Application 8 Southeast Asia Rotavirus Infections Drug (Volume, Value and Sales Price) 8.1 Southeast Asia Rotavirus Infections Drug Sales and Value (2012-2017) 8.1.1 Southeast Asia Rotavirus Infections Drug Sales Volume and Growth Rate (2012-2017) 8.1.2 Southeast Asia Rotavirus Infections Drug Revenue and Growth Rate (2012-2017) 8.1.3 Southeast Asia Rotavirus Infections Drug Sales Price Trend (2012-2017) 8.2 Southeast Asia Rotavirus Infections Drug Sales Volume and Market Share by Type 8.3 Southeast Asia Rotavirus Infections Drug Sales Volume and Market Share by Application 9 Australia Rotavirus Infections Drug (Volume, Value and Sales Price) 9.1 Australia Rotavirus Infections Drug Sales and Value (2012-2017) 9.1.1 Australia Rotavirus Infections Drug Sales Volume and Growth Rate (2012-2017) 9.1.2 Australia Rotavirus Infections Drug Revenue and Growth Rate (2012-2017) 9.1.3 Australia Rotavirus Infections Drug Sales Price Trend (2012-2017) 9.2 Australia Rotavirus Infections Drug Sales Volume and Market Share by Type 9.3 Australia Rotavirus Infections Drug Sales Volume and Market Share by Application 10 Asia-Pacific Rotavirus Infections Drug Players/Suppliers Profiles and Sales Data 10.1 Beijing Minhai Biotechnology Co Ltd 10.1.1 Company Basic Information, Manufacturing Base and Competitors 10.1.2 Rotavirus Infections Drug Product Category, Application and Specification 10.1.2.1 Product A 10.1.2.2 Product B 10.1.3 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.1.4 Main Business/Business Overview 10.2 Bharat Biotech International Ltd 10.2.1 Company Basic Information, Manufacturing Base and Competitors 10.2.2 Rotavirus Infections Drug Product Category, Application and Specification 10.2.2.1 Product A 10.2.2.2 Product B 10.2.3 Bharat Biotech International Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.2.4 Main Business/Business Overview 10.3 Biological E Ltd 10.3.1 Company Basic Information, Manufacturing Base and Competitors 10.3.2 Rotavirus Infections Drug Product Category, Application and Specification 10.3.2.1 Product A 10.3.2.2 Product B 10.3.3 Biological E Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.3.4 Main Business/Business Overview 10.4 Curevac AG 10.4.1 Company Basic Information, Manufacturing Base and Competitors 10.4.2 Rotavirus Infections Drug Product Category, Application and Specification 10.4.2.1 Product A 10.4.2.2 Product B 10.4.3 Curevac AG Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.4.4 Main Business/Business Overview 10.5 Medicago Inc 10.5.1 Company Basic Information, Manufacturing Base and Competitors 10.5.2 Rotavirus Infections Drug Product Category, Application and Specification 10.5.2.1 Product A 10.5.2.2 Product B 10.5.3 Medicago Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.5.4 Main Business/Business Overview 10.6 Nanotherapeutics Inc 10.6.1 Company Basic Information, Manufacturing Base and Competitors 10.6.2 Rotavirus Infections Drug Product Category, Application and Specification 10.6.2.1 Product A 10.6.2.2 Product B 10.6.3 Nanotherapeutics Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.6.4 Main Business/Business Overview 10.7 Serum Institute of India Ltd 10.7.1 Company Basic Information, Manufacturing Base and Competitors 10.7.2 Rotavirus Infections Drug Product Category, Application and Specification 10.7.2.1 Product A 10.7.2.2 Product B 10.7.3 Serum Institute of India Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.7.4 Main Business/Business Overview 10.8 UMN Pharma Inc 10.8.1 Company Basic Information, Manufacturing Base and Competitors 10.8.2 Rotavirus Infections Drug Product Category, Application and Specification 10.8.2.1 Product A 10.8.2.2 Product B 10.8.3 UMN Pharma Inc Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.8.4 Main Business/Business Overview 10.9 Wuhan Institute of Biological Products Co Ltd 10.9.1 Company Basic Information, Manufacturing Base and Competitors 10.9.2 Rotavirus Infections Drug Product Category, Application and Specification 10.9.2.1 Product A 10.9.2.2 Product B 10.9.3 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017) 10.9.4 Main Business/Business Overview 11 Rotavirus Infections Drug Manufacturing Cost Analysis 11.1 Rotavirus Infections Drug Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.1.2 Price Trend of Key Raw Materials 11.1.3 Key Suppliers of Raw Materials 11.1.4 Market Concentration Rate of Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Manufacturing Process Analysis of Rotavirus Infections Drug 12 Industrial Chain, Sourcing Strategy and Downstream Buyers 12.1 Rotavirus Infections Drug Industrial Chain Analysis 12.2 Upstream Raw Materials Sourcing 12.3 Raw Materials Sources of Rotavirus Infections Drug Major Manufacturers in 2016 12.4 Downstream Buyers 13 Marketing Strategy Analysis, Distributors/Traders 13.1 Marketing Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Development Trend 13.2 Market Positioning 13.2.1 Pricing Strategy 13.2.2 Brand Strategy 13.2.3 Target Client 13.3 Distributors/Traders List 14 Market Effect Factors Analysis 14.1 Technology Progress/Risk 14.1.1 Substitutes Threat 14.1.2 Technology Progress in Related Industry 14.2 Consumer Needs/Customer Preference Change 14.3 Economic/Political Environmental Change 15 Asia-Pacific Rotavirus Infections Drug Market Forecast (2017-2022) 15.1 Asia-Pacific Rotavirus Infections Drug Sales Volume, Revenue and Price Forecast (2017-2022) 15.1.1 Asia-Pacific Rotavirus Infections Drug Sales Volume and Growth Rate Forecast (2017-2022) 15.1.2 Asia-Pacific Rotavirus Infections Drug Revenue and Growth Rate Forecast (2017-2022) 15.1.3 Asia-Pacific Rotavirus Infections Drug Price and Trend Forecast (2017-2022) 15.2 Asia-Pacific Rotavirus Infections Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022) 15.2.1 Asia-Pacific Rotavirus Infections Drug Sales Volume and Growth Rate Forecast by Region (2017-2022) 15.2.2 Asia-Pacific Rotavirus Infections Drug Revenue and Growth Rate Forecast by Region (2017-2022) 15.2.3 China Rotavirus Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.4 Japan Rotavirus Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.5 South Korea Rotavirus Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.6 Taiwan Rotavirus Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.7 India Rotavirus Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.8 Southeast Asia Rotavirus Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022) 15.2.9 Australia Rotavirus Infections Drug Sales, Revenue and Growth Rate Forecast (2017-2022) 15.3 Asia-Pacific Rotavirus Infections Drug Sales, Revenue and Price Forecast by Type (2017-2022) 15.3.1 Asia-Pacific Rotavirus Infections Drug Sales Forecast by Type (2017-2022) 15.3.2 Asia-Pacific Rotavirus Infections Drug Revenue Forecast by Type (2017-2022) 15.3.3 Asia-Pacific Rotavirus Infections Drug Price Forecast by Type (2017-2022) 15.4 Asia-Pacific Rotavirus Infections Drug Sales Forecast by Application (2017-2022) 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology/Research Approach 17.1.1 Research Programs/Design 17.1.2 Market Size Estimation 17.1.3 Market Breakdown and Data Triangulation 17.2 Data Source 17.2.1 Secondary Sources 17.2.2 Primary Sources 17.3 Disclaimer

List of Tables and Figures Figure Product Picture of Rotavirus Infections Drug Figure Asia-Pacific Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2022) Figure Asia-Pacific Rotavirus Infections Drug Sales Volume Market Share by Type (Product Category) in 2016 Figure RV-3BB Product Picture Figure RV-625 Product Picture Figure UMN-2001 Product Picture Figure Rotavac-5C Product Picture Figure Others Product Picture Figure Asia-Pacific Rotavirus Infections Drug Sales (K Pcs) by Application (2012-2022) Figure Asia-Pacific Sales Market Share of Rotavirus Infections Drug by Application in 2016 Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Others Examples Table Key Downstream Customer in Others Figure Asia-Pacific Rotavirus Infections Drug Market Size (Million USD) by Region (2012-2022) Figure China Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Japan Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure South Korea Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Taiwan Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure India Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Southeast Asia Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Australia Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Rotavirus Infections Drug Sales Volume (K Pcs) and Growth Rate (2012-2022) Figure Asia-Pacific Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2022) Figure Asia-Pacific Rotavirus Infections Drug Market Major Players Product Sales Volume (K Pcs)(2012-2017) Table Asia-Pacific Rotavirus Infections Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Sales Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Rotavirus Infections Drug Sales Share by Players/Suppliers Figure 2017 Asia-Pacific Rotavirus Infections Drug Sales Share by Players/Suppliers Figure Asia-Pacific Rotavirus Infections Drug Market Major Players Product Revenue (Million USD) 2012-2017 Table Asia-Pacific Rotavirus Infections Drug Revenue (Million USD) by Players/Suppliers (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Revenue Share by Players/Suppliers (2012-2017) Figure 2016 Asia-Pacific Rotavirus Infections Drug Revenue Share by Players Figure 2017 Asia-Pacific Rotavirus Infections Drug Revenue Share by Players Table Asia-Pacific Rotavirus Infections Drug Sales and Market Share by Type (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Sales Share by Type (2012-2017) Figure Sales Market Share of Rotavirus Infections Drug by Type (2012-2017) Figure Asia-Pacific Rotavirus Infections Drug Sales Growth Rate by Type (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Revenue (Million USD) and Market Share by Type (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Revenue Share by Type (2012-2017) Figure Revenue Market Share of Rotavirus Infections Drug by Type (2012-2017) Figure Asia-Pacific Rotavirus Infections Drug Revenue Growth Rate by Type (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Sales Share by Region (2012-2017) Figure Sales Market Share of Rotavirus Infections Drug by Region (2012-2017) Figure Asia-Pacific Rotavirus Infections Drug Sales Market Share by Region in 2016 Table Asia-Pacific Rotavirus Infections Drug Revenue (Million USD) and Market Share by Region (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Revenue Share (%) by Region (2012-2017) Figure Revenue Market Share of Rotavirus Infections Drug by Region (2012-2017) Figure Asia-Pacific Rotavirus Infections Drug Revenue Market Share by Region in 2016 Table Asia-Pacific Rotavirus Infections Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017) Table Asia-Pacific Rotavirus Infections Drug Sales Share (%) by Application (2012-2017) Figure Asia-Pacific Rotavirus Infections Drug Sales Market Share by Application (2012-2017) Figure Asia-Pacific Rotavirus Infections Drug Sales Market Share by Application (2012-2017) Figure China Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure China Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2017) Figure China Rotavirus Infections Drug Sales Price (USD/Pcs) Trend (2012-2017) Table China Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2017) Table China Rotavirus Infections Drug Sales Volume Market Share by Type (2012-2017) Figure China Rotavirus Infections Drug Sales Volume Market Share by Type in 2016 Table China Rotavirus Infections Drug Sales Volume (K Pcs) by Applications (2012-2017) Table China Rotavirus Infections Drug Sales Volume Market Share by Application (2012-2017) Figure China Rotavirus Infections Drug Sales Volume Market Share by Application in 2016 Figure Japan Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Japan Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2017) Figure Japan Rotavirus Infections Drug Sales Price (USD/Pcs) Trend (2012-2017) Table Japan Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2017) Table Japan Rotavirus Infections Drug Sales Volume Market Share by Type (2012-2017) Figure Japan Rotavirus Infections Drug Sales Volume Market Share by Type in 2016 Table Japan Rotavirus Infections Drug Sales Volume (K Pcs) by Applications (2012-2017) Table Japan Rotavirus Infections Drug Sales Volume Market Share by Application (2012-2017) Figure Japan Rotavirus Infections Drug Sales Volume Market Share by Application in 2016 Figure South Korea Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure South Korea Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2017) Figure South Korea Rotavirus Infections Drug Sales Price (USD/Pcs) Trend (2012-2017) Table South Korea Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2017) Table South Korea Rotavirus Infections Drug Sales Volume Market Share by Type (2012-2017) Figure South Korea Rotavirus Infections Drug Sales Volume Market Share by Type in 2016 Table South Korea Rotavirus Infections Drug Sales Volume (K Pcs) by Applications (2012-2017) Table South Korea Rotavirus Infections Drug Sales Volume Market Share by Application (2012-2017) Figure South Korea Rotavirus Infections Drug Sales Volume Market Share by Application in 2016 Figure Taiwan Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Taiwan Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2017) Figure Taiwan Rotavirus Infections Drug Sales Price (USD/Pcs) Trend (2012-2017) Table Taiwan Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2017) Table Taiwan Rotavirus Infections Drug Sales Volume Market Share by Type (2012-2017) Figure Taiwan Rotavirus Infections Drug Sales Volume Market Share by Type in 2016 Table Taiwan Rotavirus Infections Drug Sales Volume (K Pcs) by Applications (2012-2017) Table Taiwan Rotavirus Infections Drug Sales Volume Market Share by Application (2012-2017) Figure Taiwan Rotavirus Infections Drug Sales Volume Market Share by Application in 2016 Figure India Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure India Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2017) Figure India Rotavirus Infections Drug Sales Price (USD/Pcs) Trend (2012-2017) Table India Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2017) Table India Rotavirus Infections Drug Sales Volume Market Share by Type (2012-2017) Figure India Rotavirus Infections Drug Sales Volume Market Share by Type in 2016 Table India Rotavirus Infections Drug Sales Volume (K Pcs) by Application (2012-2017) Table India Rotavirus Infections Drug Sales Volume Market Share by Application (2012-2017) Figure India Rotavirus Infections Drug Sales Volume Market Share by Application in 2016 Figure Southeast Asia Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Southeast Asia Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2017) Figure Southeast Asia Rotavirus Infections Drug Sales Price (USD/Pcs) Trend (2012-2017) Table Southeast Asia Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2017) Table Southeast Asia Rotavirus Infections Drug Sales Volume Market Share by Type (2012-2017) Figure Southeast Asia Rotavirus Infections Drug Sales Volume Market Share by Type in 2016 Table Southeast Asia Rotavirus Infections Drug Sales Volume (K Pcs) by Applications (2012-2017) Table Southeast Asia Rotavirus Infections Drug Sales Volume Market Share by Application (2012-2017) Figure Southeast Asia Rotavirus Infections Drug Sales Volume Market Share by Application in 2016 Figure Australia Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Australia Rotavirus Infections Drug Revenue (Million USD) and Growth Rate (2012-2017) Figure Australia Rotavirus Infections Drug Sales Price (USD/Pcs) Trend (2012-2017) Table Australia Rotavirus Infections Drug Sales Volume (K Pcs) by Type (2012-2017) Table Australia Rotavirus Infections Drug Sales Volume Market Share by Type (2012-2017) Figure Australia Rotavirus Infections Drug Sales Volume Market Share by Type in 2016 Table Australia Rotavirus Infections Drug Sales Volume (K Pcs) by Applications (2012-2017) Table Australia Rotavirus Infections Drug Sales Volume Market Share by Application (2012-2017) Figure Australia Rotavirus Infections Drug Sales Volume Market Share by Application in 2016 Table Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Basic Information List Table Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Bharat Biotech International Ltd Rotavirus Infections Drug Basic Information List Table Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Bharat Biotech International Ltd Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Bharat Biotech International Ltd Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Bharat Biotech International Ltd Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Biological E Ltd Rotavirus Infections Drug Basic Information List Table Biological E Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Biological E Ltd Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Biological E Ltd Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Biological E Ltd Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Curevac AG Rotavirus Infections Drug Basic Information List Table Curevac AG Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Curevac AG Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Curevac AG Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Curevac AG Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Medicago Inc Rotavirus Infections Drug Basic Information List Table Medicago Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Medicago Inc Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Medicago Inc Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Medicago Inc Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Nanotherapeutics Inc Rotavirus Infections Drug Basic Information List Table Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Nanotherapeutics Inc Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Nanotherapeutics Inc Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Nanotherapeutics Inc Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Serum Institute of India Ltd Rotavirus Infections Drug Basic Information List Table Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Serum Institute of India Ltd Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Serum Institute of India Ltd Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Serum Institute of India Ltd Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table UMN Pharma Inc Rotavirus Infections Drug Basic Information List Table UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure UMN Pharma Inc Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure UMN Pharma Inc Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure UMN Pharma Inc Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Basic Information List Table Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales (K Pcs) and Growth Rate (2012-2017) Figure Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Sales Market Share in Asia-Pacific (2012-2017) Figure Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Revenue Market Share in Asia-Pacific (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price (USD/Pcs) Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Rotavirus Infections Drug Figure Manufacturing Process Analysis of Rotavirus Infections Drug Figure Rotavirus Infections Drug Industrial Chain Analysis Table Raw Materials Sources of Rotavirus Infections Drug Major Manufacturers in 2016 Table Major Buyers of Rotavirus Infections Drug Table Distributors/Traders List Figure Asia-Pacific Rotavirus Infections Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Price (USD/Pcs) and Trend Forecast (2017-2022) Table Asia-Pacific Rotavirus Infections Drug Sales Volume (K Pcs) Forecast by Region (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Sales Volume Market Share Forecast by Region (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Sales Volume Market Share Forecast by Region in 2022 Table Asia-Pacific Rotavirus Infections Drug Revenue (Million USD) Forecast by Region (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Revenue Market Share Forecast by Region (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Revenue Market Share Forecast by Region in 2022 Figure China Rotavirus Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure China Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Japan Rotavirus Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure Japan Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure South Korea Rotavirus Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure South Korea Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Taiwan Rotavirus Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure Taiwan Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure India Rotavirus Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure India Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Southeast Asia Rotavirus Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure Southeast Asia Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure Australia Rotavirus Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022) Figure Australia Rotavirus Infections Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022) Table Asia-Pacific Rotavirus Infections Drug Sales (K Pcs) Forecast by Type (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Sales Market Share Forecast by Type (2017-2022) Table Asia-Pacific Rotavirus Infections Drug Revenue (Million USD) Forecast by Type (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Revenue Market Share Forecast by Type (2017-2022) Table Asia-Pacific Rotavirus Infections Drug Price (USD/Pcs) Forecast by Type (2017-2022) Table Asia-Pacific Rotavirus Infections Drug Sales (K Pcs) Forecast by Application (2017-2022) Figure Asia-Pacific Rotavirus Infections Drug Sales Market Share Forecast by Application (2017-2022) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources